These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6972209)

  • 21. [Impairment of color vision in glaucoma].
    Gheorghiu M
    Oftalmologia; 1997; 41(2):33-8. PubMed ID: 15328639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Color vision in Stargardt's disease.
    Mäntyjärvi M; Tuppurainen K
    Int Ophthalmol; 1992 Nov; 16(6):423-8. PubMed ID: 1490833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting glaucomatous sensitivity loss using perimetric color saturation test.
    Kogure S; Chiba T; Saito S; Iijima H; Tsukahara S
    Jpn J Ophthalmol; 2003; 47(6):537-42. PubMed ID: 14636841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tokyo Medical College Test in acquired dyschromatopsia.
    Pinckers A
    Ophthalmologica; 1980; 181(1):7-12. PubMed ID: 6970911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of X-Chrom lens wear on chromatic discrimination and stereopsis in color-deficient observers.
    Matsumoto ER; Johnson CA; Post RB
    Am J Optom Physiol Opt; 1983 Apr; 60(4):297-302. PubMed ID: 6602553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Color vision deficit in normal-tension glaucoma eyes.
    Yamagami J; Koseki N; Araie M
    Jpn J Ophthalmol; 1995; 39(4):384-9. PubMed ID: 8926646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of Rayleigh and Moreland test results using anomaloscope in young adults without color vision disorders.
    Zabel J; Przekoracka-Krawczyk A; Olszewski J; Michalak KP
    PLoS One; 2021; 16(5):e0251903. PubMed ID: 34019572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determining a standard for the diagnosis of blue-yellow defects in the F-M 100 hue test].
    Kitahara K; Kandatsu A; Noji J; Kitahara H
    Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):229-32. PubMed ID: 3486555
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of a new anomaloscope test in diagnosis of glaucoma].
    Nguyen NX; Korth M; Wisse M; Jünemann A
    Klin Monbl Augenheilkd; 1994 Mar; 204(3):149-54. PubMed ID: 8196300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of acquired color vision deficiency in glaucoma using the Rabin cone contrast test.
    Niwa Y; Muraki S; Naito F; Minamikawa T; Ohji M
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6686-90. PubMed ID: 25168899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the Worth 4 Dot Test in Patients with Red-Green Color Vision Defect.
    Bak E; Yang HK; Hwang JM
    Optom Vis Sci; 2017 May; 94(5):626-629. PubMed ID: 28234793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Color-axis determination on the Farnsworth-Munsell 100-hue test.
    Smith VC; Pokorny J; Pass AS
    Am J Ophthalmol; 1985 Jul; 100(1):176-82. PubMed ID: 3874549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease.
    Piro A; Tagarelli A; Nicoletti G; Scannapieco S; Polidoro S; Valentino P; Quattrone A
    Int Ophthalmol; 2019 Mar; 39(3):671-676. PubMed ID: 29392642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):645-50. PubMed ID: 8489447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macular colour contrast sensitivity in ocular hypertension and glaucoma: evidence for two types of defect.
    Falcao-Reis FM; O'Sullivan F; Spileers W; Hogg C; Arden GB
    Br J Ophthalmol; 1991 Oct; 75(10):598-602. PubMed ID: 1954208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J; Dain SJ
    Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colour vision as a diagnostic aid.
    Pinckers A
    Doc Ophthalmol; 1982 Jan; 52(3-4):393-6. PubMed ID: 6978241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired colour vision defects in glaucoma-their detection and clinical significance.
    Pacheco-Cutillas M; Edgar DF; Sahraie A
    Br J Ophthalmol; 1999 Dec; 83(12):1396-402. PubMed ID: 10574822
    [No Abstract]   [Full Text] [Related]  

  • 39. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
    Katz B
    Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing of colour vision for vocational purposes.
    Aarnisalo E
    Acta Ophthalmol Suppl; 1984; 161():135-8. PubMed ID: 6328845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.